IVF 2.0 revolutionises fertility assessment with launch of SiD 2.0

IVF 2.0, a leader in artificial intelligence (AI) solutions for the fertility sector, has announced the launch of SiD 2.0, a major upgrade to its cutting-edge sperm assessment software.

SiD 2.0 introduces a suite of powerful advancements, including a significantly improved scoring algorithm, a revolutionary new object identification tool, and robust reporting capabilities.

Traditionally, clinical embryologists’ selection of a single sperm for human fertilisation lacks evidence-based criteria and relies heavily on subjective judgement. However, AI-powered SiD software significantly improves this process by providing instant and data-driven assistance.

“SiD 2.0 represents a unique and pioneering leap in sperm evaluation,” said Jacques Cohen, CSO of IVF 2.0.

Our deep learning models have been refined to deliver even greater precision and reliability, empowering fertility clinics with the insights they need to make the most informed decisions for their patients. This AI software is unique in the IVF.”

Key enhancements in SiD 2.0:

• Optimized scoring algorithm: The core scoring algorithm has been meticulously refined, ensuring that assessments are more accurate than ever before.
• Object identification: A breakthrough in image analysis, SiD 2.0 can now identify morphological abnormalities in motile spermatozoa, providing Embryologists with a more detailed assessment of sperm to fertilize human eggs.
• Comprehensive reporting: SiD 2.0 generates detailed reports that explain the rationale behind AI-generated scores, enhancing transparency and clinical decision-making.

We understand that trust is paramount in the fertility field,” said Professor Andrew Drakeley, MD of IVF 2.0.

“SiD 2.0’s advanced features are designed to augment, not replace, embryologists’ expertise. We aim to provide indispensable tools that support their work and help deliver optimized patient outcomes.”

IVF 2.0 is committed to driving innovation in reproductive medicine. SiD 2.0’s release marks a significant milestone in using AI to increase the chances of successful IVF treatment.

This comes amid unprecedented growth at the company, which has its software now deployed to over 70 clinics in 30 countries and partnerships with 14 distribution networks.

About IVF 2.0

IVF 2.0 is a pioneering technology company dedicated to transforming fertility care through AI. Based in London, the company develops cutting-edge AI software designed to improve embryo and sperm assessment, optimise treatment protocols, and enhance the overall IVF experience for patients and clinicians worldwide.